Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study

INTRODUCTION: The question of whether pioglitazone, an antidiabetic drug, increases the risk of cancer has been debated for some time. Recent studies have shown that pioglitazone use can increase the risk of prostate cancer as well as pancreatic cancer. However, it is unclear whether pioglitazone is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Weiheng, Wu, Peili, Gong, Jinru, Zhao, Min, Zhang, Zhen, Chen, Rongping, Chen, Hong, Sun, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250638/
https://www.ncbi.nlm.nih.gov/pubmed/30255424
http://dx.doi.org/10.1007/s13300-018-0509-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250638/
https://www.ncbi.nlm.nih.gov/pubmed/30255424
http://dx.doi.org/10.1007/s13300-018-0509-y

Ejemplares similares